Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

It's All Over But The Signing: Patent Reform Bill Passes Senate Without Amendments

This article was originally published in The Pink Sheet Daily

Executive Summary

Senate tables an amendment that would have scuttled the House compromise on PTO fee diversion, keeps intact provision extending time to file for patent term extension.

You may also be interested in...



White House Credits Eli Lilly With Help In Final Deal On Patent Reform Bill

At President Obama's urging the CEOs of Lilly and Cisco met with Commerce Department officials to hammer out their differences to get the legislation through Congress.

White House Credits Eli Lilly With Help In Final Deal On Patent Reform Bill

At President Obama's urging the CEOs of Lilly and Cisco met with Commerce Department officials to hammer out their differences to get the legislation through Congress.

GPhA's New CEO Ralph Neas Brings Health Reform Advocacy Experience

When Ralph Neas joins the Generic Pharmaceutical Association as CEO on Sept. 12 he will face many of the same challenges he’s had as CEO of the National Coalition on Health Care: energizing reform-minded partners to advocate for legislative and policy changes.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS072863

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel